Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials—Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop

Patients of African ancestry are not well-represented in cancer clinical trials despite bearing a disproportionate share of mortality both in United States and Africa. We describe key stakeholder perspectives and priorities related to bringing early-stage cancer clinical trials to Africa and outline...

Descripción completa

Detalles Bibliográficos
Autores principales: Kizub, Darya, Manner, Cathyryne K., Graef, Katy, Abubakar, Bello, Orem, Jackson, Odedina, Folakemi, Adeyeye, Mojisola Christianah, Nakigudde, Gertrude, Ayalew, Kassa, Kalidas, Chitkala, Lyerly, Herbert Kim, Norman, Thea, Fashoyin-Aje, Lola, Freedman, Jamie, Dent, Jennifer, Cance, Bill, Gralow, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
SPECIAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232363/
https://www.ncbi.nlm.nih.gov/pubmed/35714309
http://dx.doi.org/10.1200/GO.22.00117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232363/
https://www.ncbi.nlm.nih.gov/pubmed/35714309
http://dx.doi.org/10.1200/GO.22.00117

Ejemplares similares